Regarding the subtypes and risk factors of basal cell carcinoma, all of the following statements are correct EXCEPT:

Explanation

## BCC Subtypes and Risk Stratification ### Key Point: **Superficial BCC is the LEAST aggressive subtype, not the most.** It has the best prognosis, lowest recurrence rate, and does NOT require wide margins or adjuvant therapy. The statement conflates superficial BCC with aggressive subtypes. ### BCC Subtypes: Aggressiveness Hierarchy | Subtype | Frequency | Aggressiveness | Recurrence Risk | Key Features | |---------|-----------|-----------------|-----------------|---------------| | **Nodular** | 80% | Low–moderate | 5–10% | Pearly nodule, rolled edges | | **Superficial** | 15% | **Lowest** | 2–5% | Erythematous patch, slow growth | | **Infiltrative** | 3% | **High** | 15–20% | Ill-defined borders, fibrosis | | **Micronodular** | 2% | **High** | 15–20% | Small nests, perineural invasion | | **Basosquamous** | <1% | **Highest** | 20–30% | Mixed features, aggressive behavior | ### High-Yield: Superficial BCC Characteristics **Key Point:** Superficial BCC is the **most indolent subtype** and: - Presents as a slow-growing erythematous patch or plaque - Confined to superficial dermis - Lowest recurrence rate (2–5%) - Can be treated with topical agents (imiquimod, 5-FU) or cryotherapy - Requires only 4 mm margins for complete excision - **Does NOT require adjuvant radiotherapy or chemotherapy** ### Aggressive Subtypes (Options 0 is TRUE) **Option 0 (TRUE):** Infiltrative and micronodular subtypes: - Show ill-defined borders and perineural invasion - Recurrence rates 15–20% - Require wider margins (6–10 mm) and Mohs surgery - May benefit from adjuvant radiotherapy if margins are involved ### Gorlin Syndrome (Option 1 is TRUE) **Clinical Pearl:** Nevoid basal cell carcinoma syndrome: - **Autosomal dominant** inheritance - **PTCH1 gene mutation** (patched homolog 1) - Develops 100–1000 BCCs in lifetime (typically by age 40) - Associated with: - Palmoplantar pits (pathognomonic) - Jaw cysts (odontogenic keratocysts) - Skeletal abnormalities (rib anomalies, spina bifida) - Increased risk of medulloblastoma - Requires prophylactic sun protection and frequent surveillance ### Immunosuppression (Option 3 is TRUE) **High-Yield:** Immunosuppressed patients: - Post-organ transplant recipients: 40–250× increased BCC risk - HIV/AIDS: significantly elevated incidence - Chronic corticosteroid use: increased risk - May develop multiple lesions simultaneously - Often present with more aggressive subtypes ### Why Option 2 Is Wrong Superficial BCC is the **least** aggressive subtype with: - Lowest metastatic potential (already negligible for all BCCs) - Lowest recurrence rate - Best prognosis - Can be managed with topical therapy or cryotherapy alone - Does NOT require wide margins or adjuvant radiotherapy The statement incorrectly labels superficial BCC as "most aggressive" — this is factually inverted.